Functional, cognitive and behavioral benefits of donepezil inpatients with moderate Alzheimer's disease.

被引：0
|
作者：
Feldman, H
Gauthier, S
Hecker, J
Vellas, B
Emir, B
Subbiah, P
机构：
[1] Univ British Columbia, Div Neurol, Vancouver, BC V5Z 1M9, Canada
[2] McGill Ctr Studies Aging, Verdun, PQ, Canada
[3] Repatriat Gen Hosp, Daw Pk, Australia
[4] Toulouse Univ, Alzheimers Ctr, Toulouse, France
[5] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2002年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P286
引用
收藏
页码：S104 / S105
页数：2
相关论文
共 50 条
  • [21] Memantine benefits on functional abilities in moderate to severe Alzheimer's disease
    Winblad, B.
    Hefting, N.
    Loft, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 185 - 186
  • [22] Behavioral complications in a Alzheimer's disease.
    Hughes, JC
    PSYCHOLOGICAL MEDICINE, 1998, 28 (03) : 745 - 747
  • [23] Memantine Versus Donepezil in Mild to Moderate Alzheimer's Disease. A Randomized Trial with Magnetic Resonance Spectroscopy
    Modrego, Pedro J.
    Fayed, Nicolas
    Errea, Jose M.
    Rios, Consuelo
    Pina, Miguel A.
    Sarasa, Manuel
    NEUROLOGY, 2009, 72 (11) : A298 - A298
  • [24] Review: donepezil improves cognitive and global function in people with mild to moderate Alzheimer's disease
    Whitehead, A.
    Perdomo, C.
    Pratt, R. D.
    EVIDENCE-BASED MENTAL HEALTH, 2005, 8 (01) : 15 - 15
  • [25] The benefits of donepezil in patients with moderate-to-severe Alzheimer's disease are independent of baseline dementia severity
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Xu, Y
    Ieni, J
    Schwam, E
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 258 - 258
  • [26] Short-term efficacy of donepezil in Alzheimer's disease.
    McMillan, J
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (08) : 629 - 630
  • [27] Alzheimer's disease - Donepezil improves cognitive functions
    Diener, HC
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 75 - 75
  • [28] Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
    Howard, Robert
    McShane, Rupert
    Lindesay, James
    Ritchie, Craig
    Baldwin, Ashley
    Barber, Robert
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Hughes, Alan
    Jacoby, Robin
    Jones, Rob
    Jones, Roy
    McKeith, Ian
    Macharouthu, Ajay
    O'Brien, John
    Passmore, Peter
    Sheehan, Bart
    Juszczak, Edmund
    Katona, Cornelius
    Hills, Robert
    Knapp, Martin
    Ballard, Clive
    Brown, Richard
    Banerjee, Sube
    Onions, Caroline
    Griffin, Mary
    Adams, Jessica
    Gray, Richard
    Johnson, Tony
    Bentham, Peter
    Phillips, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10): : 893 - 903
  • [29] A measure of functional reserve predicts cognitive decline in Alzheimer's disease.
    Kwee, SA
    Kun, D
    Foster, N
    Giordani, B
    Minoshima, S
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 60P - 61P
  • [30] Pharmacoeconomic benefits of donepezil treatment in severe Alzheimer's disease
    Shah, SN
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Hux, M
    Xu, Y
    Schwam, E
    Leaderer, M
    NEUROBIOLOGY OF AGING, 2004, 25 : S208 - S208
12345